Article(id=1329868988236018540, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329868906514199274, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2022.12.021, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1653840000000, receivedDateStr=2022-05-30, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794995074566, onlineDateStr=2026-11-18, pubDate=1670601600000, pubDateStr=2022-12-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794995074566, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794995074566, creator=13701087609, updateTime=1794995074566, updator=13701087609, issue=Issue{id=1329868906514199274, tenantId=1146029695717560320, journalId=1319690329412173987, year='2022', volume='43', issue='12', pageStart='1521', pageEnd='1644', issueExtLink='null', onlineDate='null', pubDate='1670601600000', pubDateStr='2022-12-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794995055082, creator='13701087609', updateTime=1794995711318, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329871659529515362, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329868906514199274, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329871659529515363, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329868906514199274, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1641, endPage=1644, ext={EN=ArticleExt(id=1329868988449928045, articleId=1329868988236018540, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Recent drug research progress on antioxidant for chronic obstructive pulmonary disease, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Chronic obstructive pulmonary disease (COPD) is a common preventable and treatable disease characterized by persistent respiratory symptoms and airflow restriction, caused by airway and/or alveolar abnormalities resulting from significant exposure to harmful particulate matter or gases. Difficulty breathing, cough and/or phlegm are the most common symptoms of COPD. The incidence and mortality of COPD are increasing year by year and is the fourth leading cause of death worldwide. Reactive oxygen species produced by cigarette smoke can damage lung structure and function, causing pulmonary oxidative stress disorder and COPD. Oxidative stress is the key to the pathogenesis of COPD. Traditional COPD drugs have limited ability to control oxidative stress, and clinical evidence of antioxidant stress is insufficient. Thioredoxin and N-acetyl-L-cysteine as molecules of the body's own antioxidant defense system have become research hotspots. This paper reviewed the pathogenesis of oxidative stress and research hotspot of antioxidants of COPD to provide reference for clinical practice.

, authors=Yujie SUN1, 2, Fenghua GU1, 2, *, authorsList=Yujie SUN, Fenghua GU, authorCompany=null, correspAuthors=Fenghua GU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329868988672226159, articleId=1329868988236018540, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=慢性阻塞性肺疾病抗氧化剂最新药物研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=

慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)是一种可以预防和治疗的常见病,以持续存在的呼吸道症状和气流受限为特征,由暴露于有害颗粒物或气体造成的气道和(或)肺泡异常所引起。呼吸困难、咳嗽和(或)咳痰是COPD的常见症状。COPD发病率和死亡率逐年上升,是全球第4大死亡原因。香烟烟雾产生的活性氧会损伤肺部结构及功能,引起肺部氧化应激失调,引发COPD。氧化应激是COPD发病机制中的关键,传统COPD治疗药物控制氧化应激的能力有限,且抗氧化应激临床证据不足,硫氧还蛋白和N-乙酰半胱氨酸作为机体自身抗氧化防御系统的分子,成为研发热点。该文对COPD氧化应激发病机制及抗氧化剂研究热点作一综述,旨在为临床提供参考。

, authors=孙玉杰1, 2, 顾丰华1, 2, *, authorsList=孙玉杰, 顾丰华, authorCompany=null, correspAuthors=顾丰华, authorNote=

孙玉杰,硕士研究生,研究方向:呼吸系统药物研究。

, correspAuthorsNote=
顾丰华,副研究员,研究方向:呼吸系统药物评价。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=RP99RUV16WAmqp0vk/RICQ==, magXml=d9hmIf66r831IhXG9kqP4Q==, pdfUrl=null, pdf=wQwUwK/CkjS2KoCxHTliZg==, pdfFileSize=1590809, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=I2KXNDyMTz4n/6QXoK6/hQ==, mapNumber=null, fund=null)}, authors=[Author(id=1329868989028742007, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329868989116822394, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, authorId=1329868989028742007, language=EN, stringName=Yujie SUN, firstName=Yujie, middleName=null, lastName=SUN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329868989188125563, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, authorId=1329868989028742007, language=CN, stringName=孙玉杰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437
2.上海市生物物质成药性评价技术服务平台,上海 200437, bio={"content":"

孙玉杰,硕士研究生,研究方向:呼吸系统药物研究。

"}, bioImg=null, bioContent=

孙玉杰,硕士研究生,研究方向:呼吸系统药物研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329868988852581232, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, xref=1., ext=[AuthorCompanyExt(id=1329868988860969841, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, companyId=1329868988852581232, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329868988873552754, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, companyId=1329868988852581232, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437)]), AuthorCompany(id=1329868988940661619, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, xref=2., ext=[AuthorCompanyExt(id=1329868988949050228, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, companyId=1329868988940661619, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China), AuthorCompanyExt(id=1329868988957438837, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, companyId=1329868988940661619, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海市生物物质成药性评价技术服务平台,上海 200437)])]), Author(id=1329868989255234429, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329868989330731904, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, authorId=1329868989255234429, language=EN, stringName=Fenghua GU, firstName=Fenghua, middleName=null, lastName=GU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329868989393646465, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, authorId=1329868989255234429, language=CN, stringName=顾丰华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437
2.上海市生物物质成药性评价技术服务平台,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329868988852581232, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, xref=1., ext=[AuthorCompanyExt(id=1329868988860969841, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, companyId=1329868988852581232, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329868988873552754, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, companyId=1329868988852581232, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437)]), AuthorCompany(id=1329868988940661619, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, xref=2., ext=[AuthorCompanyExt(id=1329868988949050228, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, companyId=1329868988940661619, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China), AuthorCompanyExt(id=1329868988957438837, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, companyId=1329868988940661619, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海市生物物质成药性评价技术服务平台,上海 200437)])])], keywords=[Keyword(id=1329868989502698370, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, language=EN, orderNo=1, keyword=chronic obstructive pulmonary disease), Keyword(id=1329868989561418627, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, language=EN, orderNo=2, keyword=antioxidant), Keyword(id=1329868989615944580, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, language=EN, orderNo=3, keyword=drug research), Keyword(id=1329868989674664837, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, language=CN, orderNo=1, keyword=慢性阻塞性肺疾病), Keyword(id=1329868989737579398, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, language=CN, orderNo=2, keyword=抗氧化剂), Keyword(id=1329868989800493959, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, language=CN, orderNo=3, keyword=药物研究)], refs=[Reference(id=1329868989901157256, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Passi M, Shahid S, Chockalingam S, et al. Conventional and nanotechnology based approaches to combat chronic obstructive pulmonary disease: implications for chronic airway diseases[J]. Int J Nanomedicine, 2020, 15: 3803-3826., articleTitle=null, refAbstract=null), Reference(id=1329868989968266121, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Checa J, Aran J M. Airway redox homeostasis and inflammation gone awry: from molecular pathogenesis to emerging therapeutics in respiratory pathology[J]. Int J Mol Sci, 2020, 21(23): 9317., articleTitle=null, refAbstract=null), Reference(id=1329868990031180682, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Barnes PJ. Oxidative stress-based therapeutics in COPD[J]. Redox Biol, 2020, 33: 101544., articleTitle=null, refAbstract=null), Reference(id=1329868990098289547, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Wang C, Zhou J, Wang J, et al. Progress in the mechanism and targeted drug therapy for COPD[J]. Signal Transduct Target Ther, 2020, 5(1): 248., articleTitle=null, refAbstract=null), Reference(id=1329868990161204109, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Kiyokawa H, Hoshino Y, Sakaguchi K, et al. Redox regulation in aging lungs and therapeutic implications of antioxidants in COPD[J]. Antioxidants (Basel), 2021, 10(9): 1429., articleTitle=null, refAbstract=null), Reference(id=1329868990245090191, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Miwa K, Kishimoto C, Nakamura H, et al. Serum thioredoxin and α-tocopherol concentrations in patients with major risk factors[J]. Circ J, 2005, 69(3): 291-294., articleTitle=null, refAbstract=null), Reference(id=1329868990316393359, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhang Q, Ju Y, Ma Y, et al. N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia: a randomized controlled trial[J]. Medicine (Baltimore), 2018, 97(45): e13087., articleTitle=null, refAbstract=null), Reference(id=1329868990379307920, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Moitra S. N-acetylcysteine (NAC) in COPD: benefits often lost in trials[J]. QJM, 2019, 112(5): 387-388., articleTitle=null, refAbstract=null), Reference(id=1329868990450611089, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Salve VT, Atram JS. N-acetylcysteine combined with home based physical activity: effect on health related quality of life in stable COPD patient-a randomised controlled trial[J]. J Clin Diagn Res, 2016, 10(12): OC16-OC19., articleTitle=null, refAbstract=null), Reference(id=1329868990505137042, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Cipollina C, Bruno A, Fasola S, et al. Cellular and molecular signatures of oxidative stress in bronchial epithelial cell models injured by cigarette smoke extract[J]. Int J Mol Sci, 2022, 23(3): 1770., articleTitle=null, refAbstract=null), Reference(id=1329868990568051603, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Hoshino Y, Mishima M. Redox-based therapeutics for lung diseases[J]. Antioxid Redox Signal, 2008, 10(4): 701-704., articleTitle=null, refAbstract=null), Reference(id=1329868990635160469, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Liu J, Huang J, Liu H, et al. Elevated serum 4HNE plus decreased serum thioredoxin: unique feature and implications for acute exacerbation of chronic obstructive pulmonary disease[J]. PLoS One, 2021, 16(1): e0245810., articleTitle=null, refAbstract=null), Reference(id=1329868990693880726, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Lewis BW, Ford ML, Rogers LK, et al. Oxidative stress promotes corticosteroid insensitivity in asthma and COPD[J]. Antioxidants (Basel), 2021, 10(9): 1335., articleTitle=null, refAbstract=null), Reference(id=1329868990752600983, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Sato A, Hoshino Y, Hara T, et al. Thioredoxin-1 ameliorates cigarette smoke-induced lung inflammation and emphysema in mice[J]. J Pharmacol Exp Ther, 2008, 325(2): 380-388., articleTitle=null, refAbstract=null), Reference(id=1329868990815515544, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Tanaka K, Kubota M, Shimoda M, et al. Thioredoxin-albumin fusion protein prevents urban aerosol-induced lung injury via suppressing oxidative stress-related neutrophil extracellular trap formation[J]. Environ Pollut, 2021, 268(Pt A): 115787., articleTitle=null, refAbstract=null), Reference(id=1329868990874235801, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Matera MG, Calzetta L, Cazzola M. Oxidation pathway and exacerbations in COPD: the role of NAC[J]. Exp Rev Respir Med, 2016, 10(1): 89-97., articleTitle=null, refAbstract=null), Reference(id=1329868990941344666, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Desaki M, Takizawa H, Kasama T, et al. Nuclear factor-κB activation in silica-induced interleukin 8 production by human bronchial epithelial cells[J]. Cytokine, 2000, 12(8): 1257-1260., articleTitle=null, refAbstract=null), Reference(id=1329868991012647835, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Wuyts WA, Vanaudenaerde BM, Dupont LJ, et al. Involvement of p38 MAPK, JNK, p42/p44 ERK and NF-κB in IL-1β-induced chemokine release in human airway smooth muscle cells[J]. Respir Med, 2003, 97(7): 811-817., articleTitle=null, refAbstract=null), Reference(id=1329868991075562396, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Zheng JP, Wen FQ, Bai CX, et al. High-dose N-acetylcysteine in the prevention of COPD exacerbations: rationale and design of the PANTHEON study[J]. COPD, 2013, 10(2): 164-171., articleTitle=null, refAbstract=null), Reference(id=1329868991134282653, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Papi A, Zheng J, Criner GJ, et al. Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: a post-hoc analysis of the PANTHEON study[J]. Respir Med, 2019, 147: 37-43., articleTitle=null, refAbstract=null), Reference(id=1329868991201391518, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Cazzola M, Rogliani P, Calzetta L, et al. Impact of mucolytic agents on COPD exacerbations: a pair-wise and network meta-analysis[J]. COPD, 2017, 14(5): 552-563., articleTitle=null, refAbstract=null), Reference(id=1329868991264306079, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Blasi F, Page C, Rossolini GM, et al. The effect of N-acetylcysteine on biofilms: implications for the treatment of respiratory tract infections[J]. Respir Med, 2016, 117: 190-197., articleTitle=null, refAbstract=null), Reference(id=1329868991323026336, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Volgers C, Benedikter BJ, Grauls GE, et al. Effects of N-acetyl-L-cysteine on the membrane vesicle release and growth of respiratory pathogens[J/OL]. FEMS Microbiol Lett, 2017, 364(9), doi: 10.1093/femsle/fnx087., articleTitle=null, refAbstract=null), Reference(id=1329868991381746593, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Cazzola M, Calzetta L, Facciolo F, et al. Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation[J]. Respir Res, 2017, 18(1): 26., articleTitle=null, refAbstract=null), Reference(id=1329868991453049762, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Calverley P, Rogliani P, Papi A. Safety of N-acetylcysteine at high doses in chronic respiratory diseases: a review[J]. Drug Saf, 2021, 44(3): 273-290., articleTitle=null, refAbstract=null), Reference(id=1329868991507575715, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Tian H, Zhou Y, Tang L, et al. High-dose N-acetylcysteine for long-term, regular treatment of early-stage chronic obstructive pulmonary disease (GOLD Ⅰ–Ⅱ): study protocol for a multicenter, double-blinded, parallel-group, randomized controlled trial in China[J]. Trials, 2020, 21(1): 780., articleTitle=null, refAbstract=null), Reference(id=1329868991570490276, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Vézina FA, Cantin AM. Antioxidants and chronic obstructive pulmonary disease[J]. Chronic Obstr Pulm Dis, 2018, 5(4): 277-288., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329868988852581232, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, xref=1., ext=[AuthorCompanyExt(id=1329868988860969841, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, companyId=1329868988852581232, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329868988873552754, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, companyId=1329868988852581232, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437)]), AuthorCompany(id=1329868988940661619, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, xref=2., ext=[AuthorCompanyExt(id=1329868988949050228, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, companyId=1329868988940661619, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China), AuthorCompanyExt(id=1329868988957438837, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, companyId=1329868988940661619, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海市生物物质成药性评价技术服务平台,上海 200437)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.12.021, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.12.021, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2022.12.021, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2022.12.021, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1670601600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
慢性阻塞性肺疾病抗氧化剂最新药物研究进展
孙玉杰 1, 2 , 顾丰华 1, 2, *
世界临床药物 | 综述评论 2022,43(12): 1641-1644
收起
收藏切换
世界临床药物 |综述评论 2022 , 43 (12) : 1641 -1644
慢性阻塞性肺疾病抗氧化剂最新药物研究进展
全屏
[Author(id=1329868989028742007, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329868989116822394, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, authorId=1329868989028742007, language=EN, stringName=Yujie SUN, firstName=Yujie, middleName=null, lastName=SUN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329868989188125563, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, authorId=1329868989028742007, language=CN, stringName=孙玉杰, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, address=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437
2.上海市生物物质成药性评价技术服务平台,上海 200437, bio={"content":"

孙玉杰,硕士研究生,研究方向:呼吸系统药物研究。

"}, bioImg=null, bioContent=

孙玉杰,硕士研究生,研究方向:呼吸系统药物研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329868988852581232, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, xref=1., ext=[AuthorCompanyExt(id=1329868988860969841, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, companyId=1329868988852581232, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329868988873552754, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, companyId=1329868988852581232, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437)]), AuthorCompany(id=1329868988940661619, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, xref=2., ext=[AuthorCompanyExt(id=1329868988949050228, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, companyId=1329868988940661619, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China), AuthorCompanyExt(id=1329868988957438837, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, companyId=1329868988940661619, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海市生物物质成药性评价技术服务平台,上海 200437)])]), Author(id=1329868989255234429, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329868989330731904, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, authorId=1329868989255234429, language=EN, stringName=Fenghua GU, firstName=Fenghua, middleName=null, lastName=GU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329868989393646465, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, authorId=1329868989255234429, language=CN, stringName=顾丰华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, *, address=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437
2.上海市生物物质成药性评价技术服务平台,上海 200437, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329868988852581232, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, xref=1., ext=[AuthorCompanyExt(id=1329868988860969841, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, companyId=1329868988852581232, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China), AuthorCompanyExt(id=1329868988873552754, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, companyId=1329868988852581232, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437)]), AuthorCompany(id=1329868988940661619, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, xref=2., ext=[AuthorCompanyExt(id=1329868988949050228, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, companyId=1329868988940661619, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China), AuthorCompanyExt(id=1329868988957438837, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329868988236018540, companyId=1329868988940661619, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.上海市生物物质成药性评价技术服务平台,上海 200437)])])]
孙玉杰1, 2, 顾丰华1, 2, *
作者信息
  • 1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437
  • 2.上海市生物物质成药性评价技术服务平台,上海 200437
通讯作者:
顾丰华,副研究员,研究方向:呼吸系统药物评价。
作者简介:

孙玉杰,硕士研究生,研究方向:呼吸系统药物研究。

Recent drug research progress on antioxidant for chronic obstructive pulmonary disease
Yujie SUN1, 2, Fenghua GU1, 2, *
Affiliations
  • 1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
  • 2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China
出版时间: 2022-12-10 doi: 10.13683/j.wph.2022.12.021
文章导航
收藏切换

慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)是一种可以预防和治疗的常见病,以持续存在的呼吸道症状和气流受限为特征,由暴露于有害颗粒物或气体造成的气道和(或)肺泡异常所引起。呼吸困难、咳嗽和(或)咳痰是COPD的常见症状。COPD发病率和死亡率逐年上升,是全球第4大死亡原因。香烟烟雾产生的活性氧会损伤肺部结构及功能,引起肺部氧化应激失调,引发COPD。氧化应激是COPD发病机制中的关键,传统COPD治疗药物控制氧化应激的能力有限,且抗氧化应激临床证据不足,硫氧还蛋白和N-乙酰半胱氨酸作为机体自身抗氧化防御系统的分子,成为研发热点。该文对COPD氧化应激发病机制及抗氧化剂研究热点作一综述,旨在为临床提供参考。

慢性阻塞性肺疾病  /  抗氧化剂  /  药物研究

Chronic obstructive pulmonary disease (COPD) is a common preventable and treatable disease characterized by persistent respiratory symptoms and airflow restriction, caused by airway and/or alveolar abnormalities resulting from significant exposure to harmful particulate matter or gases. Difficulty breathing, cough and/or phlegm are the most common symptoms of COPD. The incidence and mortality of COPD are increasing year by year and is the fourth leading cause of death worldwide. Reactive oxygen species produced by cigarette smoke can damage lung structure and function, causing pulmonary oxidative stress disorder and COPD. Oxidative stress is the key to the pathogenesis of COPD. Traditional COPD drugs have limited ability to control oxidative stress, and clinical evidence of antioxidant stress is insufficient. Thioredoxin and N-acetyl-L-cysteine as molecules of the body's own antioxidant defense system have become research hotspots. This paper reviewed the pathogenesis of oxidative stress and research hotspot of antioxidants of COPD to provide reference for clinical practice.

chronic obstructive pulmonary disease  /  antioxidant  /  drug research
孙玉杰, 顾丰华. 慢性阻塞性肺疾病抗氧化剂最新药物研究进展. 世界临床药物, 2022 , 43 (12) : 1641 -1644 . DOI: 10.13683/j.wph.2022.12.021
Yujie SUN, Fenghua GU. Recent drug research progress on antioxidant for chronic obstructive pulmonary disease[J]. World Clinical Drug, 2022 , 43 (12) : 1641 -1644 . DOI: 10.13683/j.wph.2022.12.021

参考文献 引证文献
排序方式:
[1]
Passi M, Shahid S, Chockalingam S, et al. Conventional and nanotechnology based approaches to combat chronic obstructive pulmonary disease: implications for chronic airway diseases[J]. Int J Nanomedicine, 2020, 15: 3803-3826.
[2]
Checa J, Aran J M. Airway redox homeostasis and inflammation gone awry: from molecular pathogenesis to emerging therapeutics in respiratory pathology[J]. Int J Mol Sci, 2020, 21(23): 9317.
[3]
Barnes PJ. Oxidative stress-based therapeutics in COPD[J]. Redox Biol, 2020, 33: 101544.
[4]
Wang C, Zhou J, Wang J, et al. Progress in the mechanism and targeted drug therapy for COPD[J]. Signal Transduct Target Ther, 2020, 5(1): 248.
[5]
Kiyokawa H, Hoshino Y, Sakaguchi K, et al. Redox regulation in aging lungs and therapeutic implications of antioxidants in COPD[J]. Antioxidants (Basel), 2021, 10(9): 1429.
[6]
Miwa K, Kishimoto C, Nakamura H, et al. Serum thioredoxin and α-tocopherol concentrations in patients with major risk factors[J]. Circ J, 2005, 69(3): 291-294.
[7]
Zhang Q, Ju Y, Ma Y, et al. N-acetylcysteine improves oxidative stress and inflammatory response in patients with community acquired pneumonia: a randomized controlled trial[J]. Medicine (Baltimore), 2018, 97(45): e13087.
[8]
Moitra S. N-acetylcysteine (NAC) in COPD: benefits often lost in trials[J]. QJM, 2019, 112(5): 387-388.
[9]
Salve VT, Atram JS. N-acetylcysteine combined with home based physical activity: effect on health related quality of life in stable COPD patient-a randomised controlled trial[J]. J Clin Diagn Res, 2016, 10(12): OC16-OC19.
[10]
Cipollina C, Bruno A, Fasola S, et al. Cellular and molecular signatures of oxidative stress in bronchial epithelial cell models injured by cigarette smoke extract[J]. Int J Mol Sci, 2022, 23(3): 1770.
[11]
Hoshino Y, Mishima M. Redox-based therapeutics for lung diseases[J]. Antioxid Redox Signal, 2008, 10(4): 701-704.
[12]
Liu J, Huang J, Liu H, et al. Elevated serum 4HNE plus decreased serum thioredoxin: unique feature and implications for acute exacerbation of chronic obstructive pulmonary disease[J]. PLoS One, 2021, 16(1): e0245810.
[13]
Lewis BW, Ford ML, Rogers LK, et al. Oxidative stress promotes corticosteroid insensitivity in asthma and COPD[J]. Antioxidants (Basel), 2021, 10(9): 1335.
[14]
Sato A, Hoshino Y, Hara T, et al. Thioredoxin-1 ameliorates cigarette smoke-induced lung inflammation and emphysema in mice[J]. J Pharmacol Exp Ther, 2008, 325(2): 380-388.
[15]
Tanaka K, Kubota M, Shimoda M, et al. Thioredoxin-albumin fusion protein prevents urban aerosol-induced lung injury via suppressing oxidative stress-related neutrophil extracellular trap formation[J]. Environ Pollut, 2021, 268(Pt A): 115787.
[16]
Matera MG, Calzetta L, Cazzola M. Oxidation pathway and exacerbations in COPD: the role of NAC[J]. Exp Rev Respir Med, 2016, 10(1): 89-97.
[17]
Desaki M, Takizawa H, Kasama T, et al. Nuclear factor-κB activation in silica-induced interleukin 8 production by human bronchial epithelial cells[J]. Cytokine, 2000, 12(8): 1257-1260.
[18]
Wuyts WA, Vanaudenaerde BM, Dupont LJ, et al. Involvement of p38 MAPK, JNK, p42/p44 ERK and NF-κB in IL-1β-induced chemokine release in human airway smooth muscle cells[J]. Respir Med, 2003, 97(7): 811-817.
[19]
Zheng JP, Wen FQ, Bai CX, et al. High-dose N-acetylcysteine in the prevention of COPD exacerbations: rationale and design of the PANTHEON study[J]. COPD, 2013, 10(2): 164-171.
[20]
Papi A, Zheng J, Criner GJ, et al. Impact of smoking status and concomitant medications on the effect of high-dose N-acetylcysteine on chronic obstructive pulmonary disease exacerbations: a post-hoc analysis of the PANTHEON study[J]. Respir Med, 2019, 147: 37-43.
[21]
Cazzola M, Rogliani P, Calzetta L, et al. Impact of mucolytic agents on COPD exacerbations: a pair-wise and network meta-analysis[J]. COPD, 2017, 14(5): 552-563.
[22]
Blasi F, Page C, Rossolini GM, et al. The effect of N-acetylcysteine on biofilms: implications for the treatment of respiratory tract infections[J]. Respir Med, 2016, 117: 190-197.
[23]
Volgers C, Benedikter BJ, Grauls GE, et al. Effects of N-acetyl-L-cysteine on the membrane vesicle release and growth of respiratory pathogens[J/OL]. FEMS Microbiol Lett, 2017, 364(9), doi: 10.1093/femsle/fnx087.
[24]
Cazzola M, Calzetta L, Facciolo F, et al. Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation[J]. Respir Res, 2017, 18(1): 26.
[25]
Calverley P, Rogliani P, Papi A. Safety of N-acetylcysteine at high doses in chronic respiratory diseases: a review[J]. Drug Saf, 2021, 44(3): 273-290.
[26]
Tian H, Zhou Y, Tang L, et al. High-dose N-acetylcysteine for long-term, regular treatment of early-stage chronic obstructive pulmonary disease (GOLD Ⅰ–Ⅱ): study protocol for a multicenter, double-blinded, parallel-group, randomized controlled trial in China[J]. Trials, 2020, 21(1): 780.
[27]
Vézina FA, Cantin AM. Antioxidants and chronic obstructive pulmonary disease[J]. Chronic Obstr Pulm Dis, 2018, 5(4): 277-288.
2022年第43卷第12期
10
1
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2022.12.021
  • 接收时间:2022-05-30
  • 首发时间:2026-11-18
  • 出版时间:2022-12-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2022-05-30
基金
作者信息
    1.中国医药工业研究总院创新药物与制药工艺国家重点实验室,上海 200437
    2.上海市生物物质成药性评价技术服务平台,上海 200437

通讯作者:

顾丰华,副研究员,研究方向:呼吸系统药物评价。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.12.021
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏